Literature DB >> 88474

Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.

J R Carlo, S Ruddy, E J Studer, D H Conrad.   

Abstract

Treatment of 125I-C3b bound to EAC1423b with C3b inactivator (C3bINA) and beta 1H globulin (beta 1H) cleaved the alpha-chain of C3b into 65,000- and 42,000-dalton fragments, both of which remained disulfide-bonded to the intact beta-chain (C3bi). Subsequent treatment with trypsin (0.1 microgram/ml) released 125I into the supernatant and yielded cells coated with a 33,000-dalton fragment of alpha-chain, presumably C3d. These results are in agreement with those obtained by others using fluid phase C3b. C3b-coated cells (EAC1423b) adhered to complement (C) receptors on human erythrocytes, glomeruli, and monocytes. C3bi-coated cells adhered to the receptors on glomeruli and monocytes, but not to those on human erythrocytes. C3d-coated cells adhered only to the monocyte receptors. The findings suggest that the glomerular C receptor recognizes portions of the C3 molecule different from those recognized by either the erythrocyte or monocyte receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88474

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  The pathogenesis of hyaline arteriolosclerosis.

Authors:  C N Gamble
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

2.  The complement fragment C3d facilitates phagocytosis by monocytes.

Authors:  T A Gaither; I Vargas; S Inada; M M Frank
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

3.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Authors:  J D Fingeroth; J J Weis; T F Tedder; J L Strominger; P A Biro; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 5.  The chemistry and biology of complement receptors.

Authors:  R D Schreiber
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Peripheral T gamma lymphocyte population in head and neck cancer.

Authors:  Y Hayashi; T Nishida; H Yoshida; T Yanagawa; Y Yura; N Furumoto; M Sato
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.

Authors:  M D Kazatchkine; D T Fearon; M D Appay; C Mandet; J Bariety
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Human complement (C3b) receptors defined by a mouse monoclonal antibody.

Authors:  J Gerdes; M Naiem; D Y Mason; H Stein
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

9.  Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

Authors:  J J Weis; T F Tedder; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  C3-mediated release of prostaglandin from human monocytes. Behaviour in short-term culture.

Authors:  H A Schenkein; B Rutherford
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.